An osteoanabolic agent should be the first choice treatment for patients at high or imminent risk for fracture, but once ...

After emerging on the scene in the early 2000s, fracture liaison services (FLS) have solidified their place for preventing ...

The EPA-targeted rules could prevent an estimated 30,000 deaths and save $275 billion each year they are in effect, according ...

Prespecified subgroup analyses showed that primary surgery conferred greater benefits for patients with stage III disease and ...

Older adults taking GLP-1 receptor agonists, primarily semaglutide (Rybelsus, Ozempic, Wegovy), had a small uptick in their ...

Contrast-enhanced dual-energy CT (CE-DECT) imaging offers more detailed information on a wider range of tissues than ...

Michigan resident physician Nidal Jboor, MD, was arrested for protesting during Secretary of State Marco Rubio's opening ...

Home-based pulmonary rehabilitation has been slowly gaining momentum for chronic obstructive pulmonary disease (COPD), but ...

For COPD patients, the adage holds true: "the first way to get out of a hole is to quit digging one," said Christopher Mosher ...

Team's approach underscores urgency of comprehensive management to confront myriad challenges of the condition ...

The ranibizumab ocular implant (Susvimo) reduces the need for frequent intravitreal anti-VEGF injections in patients with neovascular age-related macular degeneration or diabetic macular edema, and ...

Currently, the only approved treatment for MASH on the market is the thyroid hormone receptor β agonist resmetirom (Rezdiffra ...